Anti-CD8 Anticorpo [YCATE55.9] (A282027)

$355

Anticorpo monoclonale [YCATE55.9] di ratto contro CD8 per Flow Cytometry, IHC-Fr e IF.

Alternative Formats and ConjugatesAlternative Formats

Spese di spedizione
Tempi di consegna
4-6 Giorni lavorativi
Telefono
+1 (314) 370-6046
Lun - Ven, 8:00 - 16:00 AST
E-mail
orders@antibodies.com
Nome
Anti-CD8 Antibody [YCATE55.9]
Descrizione
Rat monoclonal [YCATE55.9] antibody to CD8.
Specificità
This antibody recognises a rat cell line transfected with cDNA for canine CD8a and blocks MHC class I dependant T-cell responses in vitro and in vivo.Rat anti Dog CD8, clone YCATE55.9 has been shown to deplete circulating CD8+ T cells when administered to dogs in vivo. Reduced levels of circulating CD8+ T cells has been associated with decreased survival times for dogs with osteosarcoma.
Applicazioni
Flow Cytometry, IHC-Fr, IF
Diluizioni consigliate
Flow Cytometry: 1:50 - 1:100, Use 10µl of the suggested working dilution to label 1 x 106 cells in 100µl
Reattività
Canine
Immunogeno
Canine CD8 alpha chimaeric human IgG1 Fc fusion protein.
Specie ospite
Rat
Clonalità
Monoclonal
Clona ID
YCATE55.9
Isotipo
IgG1
Coniugare

Unconjugated

Purificazione
Protein G affinity chromatography of tissue culture supernatant.
Concentrazione
1 mg/ml
Forma del prodotto
Liquid
Formulazione
Supplied in Phosphate Buffered Saline with 0.09% Sodium Azide.
Conservazione
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
Note generali
Rat anti Dog CD8 antibody, clone YCATE55.9 was clustered as Canine CD8 in the First Canine Leukocyte Antigen Workshop (Cobbold et al. 1994). YCATE55.9 reacts with a rat cell line transfected with cDNA for canine CD8a (Gorman et al. 1994) and blocks MHC class I dependant T-cell responses in vitro and in vivo.Rat anti Dog CD8, clone YCATE55.9 has been shown to deplete circulating CD8+ T cells when administered to dogs in vivo. (Watson et al. 1993) Reduced levels of circulating CD8+ T cells has been associated with decreased survival times for dogs with osteosarcoma (Biller et al. 2010).
Sinonimi
CD8 antigen, alpha polypeptide (p32), CD8a, CD8a antigen, CD8a molecule, CD8A_HUMAN, Leu2, Leu2 T lymphocyte antigen, MAL, OKT8 T cell antigen, p32, T cell antigen Leu2, T cell co receptor, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2, T8 T cell antigen
Dichiarazione di non responsabilità
Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.

Prodotti alternativi a Anti-CD8 Anticorpo [YCATE55.9] (A282027)

Inizio pagina